ABCL
Price
$12.70
Change
+$0.05 (+0.40%)
Updated
Sep 25 closing price
Capitalization
4.12B
44 days until earnings call
Intraday BUY SELL Signals
DRTS
Price
$14.54
Change
-$0.23 (-1.56%)
Updated
Sep 25 closing price
Capitalization
1.34B
58 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

ABCL vs DRTS

ABCL vs DRTS Comparison Chart in %
View a ticker or compare two or three
VS
ABCL vs. DRTS commentary
Sep 27, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ABCL is a Buy and DRTS is a Buy.

Interact to see
Advertisement
SUMMARIES
Loading...
TECHNICAL ANALYSIS
Technical Analysis
ABCLDRTS
RSI
ODDS (%)
Bearish Trend 3 days ago
82%
N/A
Stochastic
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 3 days ago
80%
Momentum
ODDS (%)
Bullish Trend 3 days ago
85%
Bullish Trend 3 days ago
85%
MACD
ODDS (%)
Bearish Trend 3 days ago
77%
Bearish Trend 3 days ago
79%
TrendWeek
ODDS (%)
Bullish Trend 3 days ago
80%
Bearish Trend 3 days ago
77%
TrendMonth
ODDS (%)
Bullish Trend 3 days ago
79%
Bearish Trend 3 days ago
78%
Advances
ODDS (%)
Bullish Trend 3 days ago
81%
Bullish Trend 11 days ago
77%
Declines
ODDS (%)
Bearish Trend 5 days ago
83%
Bearish Trend 5 days ago
75%
BollingerBands
ODDS (%)
Bearish Trend 3 days ago
85%
Bearish Trend 3 days ago
83%
Aroon
ODDS (%)
Bullish Trend 3 days ago
78%
Bullish Trend 3 days ago
78%
COMPARISON
Comparison
Sep 27, 2026
Stock price -- (ABCL: $12.70 vs. DRTS: $14.54)
Brand notoriety: ABCL and DRTS are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ABCL: 50% vs. DRTS: 81%
Market capitalization -- ABCL: $4.12B vs. DRTS: $1.34B
ABCL [@Biotechnology] is valued at $4.12B. DRTS’s [@Biotechnology] market capitalization is $1.34B. The market cap for tickers in the [@Biotechnology] industry ranges from $58 to $133.37B. The average market capitalization across the [@Biotechnology] industry is $2.2B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ABCL’s FA Score shows that 0 FA rating(s) are green while DRTS’s FA Score has 0 green FA rating(s).

  • ABCL’s FA Score: 0 green, 5 red.
  • DRTS’s FA Score: 0 green, 5 red.
According to our system of comparison, both ABCL and DRTS are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ABCL’s TA Score shows that 3 TA indicator(s) are bullish while DRTS’s TA Score has 3 bullish TA indicator(s).

  • ABCL’s TA Score: 3 bullish, 5 bearish.
  • DRTS’s TA Score: 3 bullish, 4 bearish.
According to our system of comparison, DRTS is a better buy in the short-term than ABCL.

Price Growth

ABCL (@Biotechnology) experienced а +0.55% price change this week, while DRTS (@Biotechnology) price change was -4.59% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -4.17%. For the same industry, the average monthly price growth was -13.24%, and the average quarterly price growth was +5.35%.

Reported Earning Dates

ABCL is expected to report earnings on Nov 10, 2026.

DRTS is expected to report earnings on Nov 24, 2026.

Industries' Descriptions

@Biotechnology (-4.17% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

View a ticker or compare two or three
ABCL
Daily Signal:
Gain/Loss:
DRTS
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
WPP25.990.72
+2.85%
WPP PLC
CNDT1.640.01
+0.61%
Conduent
LZB29.88-0.03
-0.10%
La-Z-Boy
APP310.75-1.72
-0.55%
Applovin Corp
CHOW0.67-0.03
-4.71%
ChowChow Cloud International Holdings Ltd

DRTS and

Correlation & Price change

A.I.dvisor indicates that over the last year, DRTS has been loosely correlated with ORMP. These tickers have moved in lockstep 50% of the time. This A.I.-generated data suggests there is some statistical probability that if DRTS jumps, then ORMP could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To DRTS
1D Price
Change %
DRTS100%
-1.56%
ORMP - DRTS
50%
Loosely correlated
-1.25%
FDMT - DRTS
29%
Poorly correlated
-1.63%
TNXP - DRTS
29%
Poorly correlated
+1.65%
IBIO - DRTS
28%
Poorly correlated
-0.83%
ABCL - DRTS
27%
Poorly correlated
+0.40%
More